Dopamine Transporters Decrease with Age

Journal of Nuclear Medicine

Volumn 37, Issue 4-6, 1996, Pages 554-559

  Volkow, Nora D ^a   Ding, Yu Shin ^b   Fowler, Joanna S ^b   Wang, Gene Jack ^b   Logan, Jean ^b   Gatley, S John ^b   Hitzemann, Robert ^b   Smith, Gwenn ^b   Fields, Suzanne D ^b   Gur, Ruben ^b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b NONE

Author keywords

Degeneration; Dopamine transporters; PET

Indexed keywords

CARBON; CARRIER PROTEIN; DIAGNOSTIC AGENT; DOPAMINE TRANSPORTER; MEMBRANE PROTEIN; METHYLPHENIDATE; NERVE PROTEIN;

ADULT; AGED; AGING; ARTICLE; BRAIN; BRAIN LEVEL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; SCINTISCANNING;

ADULT; AGED; AGING; BRAIN; BRAIN CHEMISTRY; CARBON RADIOISOTOPES; CARRIER PROTEINS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHYLPHENIDATE; MIDDLE AGED; NERVE TISSUE PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030115973     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. U.S. Bureau of the Census. Current Population Reports, Special Studies, P23-178RV, Sixty-Five Plus in America, U.S. Government Printing Office, Washington, D.C., 1992.
2. Pradhan SN. Central neurotransmitters and aging. Life Sci 1980;26:1643-1656.
3. Battistin L, Rigo A, Bracco F, Dam M, Pizzolato G. Metabolic aspects of aging brain and related disorders. Gerontology 1987;33:253-258.
4. Joseph JA, Roth GS, Strong R. The striatum, a microcosm for the examination of age related alterations in the CNS: a selected review. Review of Biological Research in Aging 1990;4:181-199.
5. Kane JM, Weinhold P, Kinon B, Wegner J, Leader M. Prevalence of abnormal involuntary movements (spontaneous dyskinesias) in the normal elderly. Psychopharmacology 1982;77:105-108.
6. Owens DGC, Johnston EC, Frith CD. Spontaneous involuntary disorders of movement. Arch Gen Psychiatry 1982;39:452-461.
7. McGeer PL, McGeer EG, Suzuki JS. Aging and extrapyramidal function. Arch Neurol 1977;34:33-35.
8. Sabol KE, Neill DB, Wages SA, Church WH, Justice JB. Dopamine depletion in a striatal subregion disrupts performance of a skilled motor task in the rat. Brain Res 1985;335:33-43.
9. Carlsson A. Brain neurotransmitters in aging and dementia: similar changes across diagnostic dementia groups. Gerontology 1987;33:159-167.
10. Palmer AM, DeKosky ST. Monoamine neurons in aging and Alzheimer's disease. J Neur Trans 1993;91.135-159.
11. Wong DF, Wagner HN Jr, Dannals RF, et al. Effects of age on dopamine and serotonin receptors measured by PET in the living brain Science 1984;226:1393-1396.
12. 76Br]bromospiperone binding sites demonstrated by PET in progressive supranuclear palsy J Cereb Blood Flow Metab 1986;6:131-136.
13. Woda A, Alavi A, Mozley D, Galloway S. Effects of age on dopamine receptors as measured with SPECT and IBZM. J Nucl Med 1992,33:897.
14. 11C raclopride. J Cereb Blood Flow Metab 1993;13:310-314.
15. 11C-raclopride. Arch Neurol 1993;50:474-480.
16. Volkow ND, Fowler JS, Wang G-J, et al. Dopaminergic dysregulation of frontal metabolism may contribute to cocaine addiction. Synapse 1993;14:169-177.
17. Suhara T, Fukuda H, Inoue O, et al. Age related changes in human D1 dopamine receptors measured by PET Psychopharmacology 1991;103:41-45.
18. 11C-raclopride. Neurology 1994;44:2101-2104.
19. Martin WRW, Palmer MR, Patlak CS, Calne DB. Nigrostriatal function in humans studied with positron emission tomography. Ann Neurol 1989;26:535-542.
20. Sawle GV, Colebatch JG, Shah A, Brooks DJ, Marsden CD, Frackowiak RJS. Striatal function in normal aging-implications for Parkinson's disease. Ann Neurol 1990,28: 799-804.
21. 18F-DOPA uptake: absence of an aging effect. J Cereb Blood Flow Metab 1993;13:881-888.
22. 11C]nomifensine and positron emission tomography. the effects of age and Parkinson's disease. Acta Neurol Scand 1988;77: 192-201.
23. Volkow ND, Fowler JS, Wang G-J, et al. Decreased dopamine transporters with age in healthy human subjects. Ann Neurology 1994;36:237-239.
24. Van Dick CH, Seibyl JP, Malison RT, et al. Age-related decline in dopamine transporter binding in human striatum with [I-123]β-CIT SPECT. J Nucl Med 1995;36:1175-1181.
25. 11C]WIN 35,428. Synapse 1993,15:130-142.
26. Ding Y-S, Fowler JS, Volkow ND, et al. Carbon-11-d-threo-methylphenidate. a new PET ligand for the dopamine transporter I. Studies in the baboon brain. J Nucl Med 1995;36:2298-2305.
27. Volkow ND, Ding Y-S, Fowler JS, et al. Carbon-11-d-threo-methylphenidate: a new PET ligand for the dopamine transporter. II. Studies in the human brain. J Nucl Med 1995;36:2162-2168.
28. Fowler JS, Volkow ND, Wolf AP, et al. Mapping cocaine-binding sites in human and baboon brain in vivo Synapse 1989;4:371-377.
29. 11C-methyl-(-) cocaine PET studies in human subjects. J Cereb Blood Flow Metab 1989;10:740-747.
30. 11C-flumazenil. J Cereb Blood Flow Metab 1991;11:745-752.
31. 125I]iodo-benzilate transport and specific binding to muscarinic receptor in rat brain in vivo: implications for human studies. J Cereb Blood Flow Metab 1990;10:781-807.
32. Olkin I, Finn J. Testing correlated correlations. Psychol Bull 1990;108:330-333
33. Fearnley JM, Lees AJ. Aging and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283-2301.
34. Zelnik N, Angel I, Paul SM, Kleinman JE. Decreased density of human striatal dopamine uptake sites with age. Eur J Pharmacol 1986;126:175-176.
35. De Keyser J, Ebinger G, Vauquelin G. Age-related changes in the human nigrostriatal dopaminergic system. Ann Neurol 1990;27:157-161.
36. Robinson TE, Whishaw IQ. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the Substantia nigra a microdialysis study in freely moving rats. Brain Res 1988;450:209-224.
37. Kish SJ, Shannak K, Rajput A, Deck JHN, Hornykiewicz L. Aging produces a specific pattern of striatal dopamine loss: implications for the ethiology of idiopathic Parkinson's disease. J Neurochem 1992;58:642-648.
38. Farde L, Wiesel FA. Stone-Elander S, et al. D2 dopamine receptors in neurolepticnaive schizophrenic patients. Arch Gen Psychiatry 1990;47.213-219.
39. Schneider LH, Murphy RB, Coons EE. Lateralization of striatal dopamine (D2) receptors in normal rats. Neurosci Lett 1982;33:281-284.
40. Bannon MJ, Poosch MS, Xia Y, et al. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc Natl Acad Sci USA 1992,89: 7095-7099.
41. Cass WA, Gerhardt GA, Robinson S, Zhang Z, Ovadia A, Gash DM. Differences in striatal dopamine overflow and clearance between young and aged rhesus monkeys [Abstract]. Soc Neurose 1994;20:388.
42. 18F]GBR [Abstract]. J Nucl Med 1991;32(suppl):1097.
43. Marsden CD. Parkinson's disease. Lancet 1990;335:948-952.
44. 11C]methylphenidate: implications for PET studies. Eur J Pharmacol 1995; 281:141-149.